Lung cancer is the leading cause of cancer deaths in women and men both in the United States and throughout the world. Lung cancer has surpassedbreast canceras the leading cause of cancer deaths in women for the past 25 years. In the United States, there are more deaths due to lung canc...
Treatment of lung cancer is complex and requires accurate knowledge of both the anatomic stage of the tumor and the patient's overall physiologic condition. Surgical treatment of lung cancer may be an option for patients once thought to be medically unresectable, and patients with borderline physiolo...
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy. Medical management is often associated with the development of treatment resistance leading ...
As the leading cause of cancer-related mortality, lung cancer continues to pose a menacing threat to human health worldwide. Lung cancer treatment options primarily rely on chemoradiotherapy, surgery, targeted therapy, or immunotherapy. Despite significant progress in research and treatment, the 5-yea...
KEYTRUDA is used alone after surgery. Treatment after surgery is called “adjuvant.” See clinical trial results Talk to an oncologist before surgery to see if KEYTRUDA is an option for you Talking to your doctors before surgery may increase your options to help prevent lung cancer from coming...
The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.
In earlier stages of lung cancer, the cancer remains in the lungs and has not spread to lymph nodes, other tissues, or organs. Treatment goals for earlier stages of lung cancer focus on curing the cancer. Stage 4 lung cancer treatment focuses on slowing cancer’s progression, treating symptom...
刊名:Lung Cancer: Targets and Therapy 2012年第-1期 摘要:Targeted therapies are nowadays a treatment option in metastatic non-small cell lung cancer, for which oncogenic drivers have been identified. The epidermal growth factor-receptor tyrosine kinase inhibitors gefitinib and erlotinib, are...
MIT cancer biologists have identified a new therapeutic target for small cell lung cancer, an especially aggressive form of lung cancer with limited options for treatment.
Staging is important for doctors to be able to select a treatment option and a prognosis for you. It simply means, finding out which stage your cancer is at. If the spread of metastasis has begun and if it has, to which organ has the cancer spread? Small cell lung carcinoma is either...